logo
Why Rome's dolphins are fighting each other

Why Rome's dolphins are fighting each other

Yahoo25-06-2025
Rome, the Eternal City, is revered for its history, art, culture, and food. Yet, few people know that less than an hour away, where the Tiber River flows into the Tyrrhenian Sea, there's something that makes the area even more unique: a population of around 500 bottlenose dolphins.
Now, a recent study shows that the dolphins are not only sick, but they're fighting over food—and it's due to human activity.
The 'Capitoline dolphins,' as researchers have named them, have inhabited the coast outside Rome for thousands of years, as shown by mosaics from the archaeological site of Ostia Antica that depict the dolphins stealing fish from fishermen's nets 2,000 years ago. Yet they've only recently been closely studied, beginning in 2016.
Around 500 dolphins spend some of the year in the area, while about 100 are permanent residents—mostly females and their offspring who live near the mouth of the Tiber River, where food is most abundant. This makes the area an important breeding site, where males are attracted each year to mate.
Daniela Silvia Pace, a researcher at the Sapienza University of Rome, has studied these dolphins for a decade. She and her colleagues recently analyzed more than 400 photographs taken between 2016 and 2023, depicting 39 individuals of the resident population.
"What emerges is a decidedly worrying picture,' as these animals are subject to so many pressures, she says.
Pace and her team measured and counted marks on the dolphins' bodies. Analyzing marks on cetaceans is a common technique used by scientists, as it can tell them a lot about their life, their health, and the dangers they're exposed to.
The result of the new research, published in Aquatic Conservation: Marine and Freshwater Ecosystems in April, does not necessarily paint a hopeful picture. 'Unfortunately, the situation for bottlenose dolphins in the Mediterranean, including the Tiber River Estuary, appears to be particularly concerning,' says Bruno Díaz López, a biologist and director at Bottlenose Dolphin Research Institute, who was not involved with the study but found it 'very interesting and relevant.'
The analysis revealed that 70 percent of the residents studied showed signs of malnutrition, such as visible ribs. 'This is strange, because we are in an area rich in food,' says Alice Turchi, a PhD student in environmental and evolutionary biology at the Sapienza University of Rome and author of the study. Turchi and her colleagues believe that the lack of food might be due to overfishing.
'The fact that most of the population is undernourished is a strong alarm bell,' adds Pace.
In the study, the lines and ropes used by fishermen had left marks on half of the dolphins' bodies, and amputations were present as well. Nearly all, or 97 percent, of the dolphins had a skin disease, which didn't come as a shock to the researchers.
'It is not surprising,' says Turchi, because the water is tainted, mostly due to pollutants carried by the Tiber River into the sea, as well as wastewater from boats passing through. 'Pollution can promote immunodepression and cause animals to get sick,' Turchi says.
In another distressing development, researchers also found evidence of fighting. They analyzed teeth marks caused by interactions with other dolphins, which were universal across the population. While these marks are sometimes normal for dolphins, as they can bite to communicate dominance during mating competitions or to establish social hierarchies, this population showed an unusually high number. The researchers believe that this may be due to competition for dwindling food resources.
López, from the Bottlenose Dolphin Research Institute, says the findings on the Capitoline dolphins' health 'are consistent with what we observe in many coastal bottlenose dolphin populations worldwide.'
'These populations are exposed to continuous and intense pressure from human activities, ranging from fisheries and maritime traffic to pollution and habitat degradation,' he notes.
For example, he says, 'in Galicia, on the Atlantic coast of Spain, we see similar patterns of skin marks related to both natural and anthropogenic factors.' Similarly, he says, 'studies from other regions—such as Sarasota Bay in the United States or various sites in Australia—also report high frequencies of marks linked to social interactions, fishing gear, boat strikes, and skin diseases.'
While bottlenose dolphins are an adaptable species and can show great resilience, the researchers are worried about the future of this population. The area is currently 'unmanaged,' says Turchi, meaning that almost no conservation actions are carried out to protect this slice of coast. 'There is a need to carry out interventions to safeguard this population, which is unique.'
The team says that it would be necessary to establish a Site of Community Importance, which would help the conservation of this population and the whole rich ecosystem found off this coast. But the process to establish such a site is 'very complex,' says Pace, and would need to run up the political chain.
The researchers hope that making this population known to the general public could be a step in the right direction to ensure that politicians will be more motivated to implement conservation actions aimed at protecting the area.
'It is important to take into account that this area is important for this species, and it is also important for our species,' says Turchi. 'We should try as much as possible to reconcile human exploitation with the conservation of biodiversity.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mysterious 2,500-Year-Old 'Gift to The Gods' Finally Identified
Mysterious 2,500-Year-Old 'Gift to The Gods' Finally Identified

Yahoo

time15 minutes ago

  • Yahoo

Mysterious 2,500-Year-Old 'Gift to The Gods' Finally Identified

A mysterious, orange gunk found in a bronze jar uncovered some 70 years ago at an ancient shrine near Pompeii, Italy, has finally been identified as honey. After several failed attempts over recent decades, researchers from the University of Oxford unraveled the strange substance's chemical degradation to reveal a sweet offering to an ancient Greek god 2,500 years ago; an appropriate gift, given honey is said to be what Zeus ate as a child. Archeologist Luciana da Costa Carvalho and colleagues were able to detect a chemical fingerprint nearly identical to modern honey and beeswax using advanced gas chromatography and mass spectrometry techniques. It was more acidic though, as would be expected from long-term storage where the sugars degrade into furans over time. Related: This also happens to beeswax, which was identified in one of the previous analyses, but the residue had a much more complicated composition to just be wax, the researchers argue. While previous analyses were unable to detect any carbohydrates, the new analysis picked up the simple sugar hexose and the products of decomposed saccharides preserved in the corroded copper of the jar. Excavated in 1954, the shrine at a Greek settlement in Paestum, Italy, was dedicated to an unknown deity. Inside, bronze jars surrounded an empty iron bed accompanied by six hydriai and two amphorae. "The empty bed and the inaccessibility of the shrine signify that the deity was there," da Costa Carvalho and team describe in their paper, explaining honey is a "symbol of immortality". Honey was also well known for its use as a sweetener and in medical preparations, cosmetics, and rituals in ancient Greece. "Ancient residues aren't just traces of what people ate or offered to the gods – they are complex chemical ecosystems," says da Costa Carvalho. "Studying them reveals how those substances changed over time, opening the door to future work on ancient microbial activity and its possible applications." This research was published in the Journal of the American Chemical Society. Related News 4,000-Year-Old Handprint Discovered on Ancient Egyptian Artifact Markings on Strange Stonehenge Boulder May Not Be Natural After All Stomach-Churning Theory Could Explain Mystery of Neanderthal Diet Solve the daily Crossword

Deaths From Prostate Cancer vs Other Causes: Long-Term Data
Deaths From Prostate Cancer vs Other Causes: Long-Term Data

Medscape

time3 hours ago

  • Medscape

Deaths From Prostate Cancer vs Other Causes: Long-Term Data

Men treated for nonmetastatic prostate cancer under current guidelines are up to 6 times less likely to die from their cancer than from other causes, according to data from a Swedish cancer registry. The study estimated long-term outcomes over up to 30 years in men who received treatment for nonmetastatic prostate cancer that was in line with current National Comprehensive Cancer Network (NCCN) guidelines. Overall, nearly 90% of men with low-risk or favorable intermediate-risk disease were likely to survive their cancer and die from other causes over their life expectancy. While men with high-risk disease had higher death rates from prostate cancer, they were still at least twice as likely to die from other causes. 'Our data support adherence to guideline recommendations for treatment of prostate cancer,' lead author Pietro Scilipoti, MD, of Uppsala University in Uppsala, Sweden, and IRCCS San Raffaele Hospital in Milan, Italy, said in a news release. 'If guideline-recommended treatment is used,' Scilipoti added, 'most people with prostate cancer will live for many years after diagnosis. That includes active surveillance as an excellent treatment strategy for appropriately selected people.' Kyrollis Attalla, MD, a urologic oncologist at Mount Sinai Hospital in New York City, emphasized the findings among low-risk patients, most of whom underwent active surveillance. The data offer a 'strong and welcome addition to the existing and growing body of evidence demonstrating the superior clinical outcomes among men with low-risk prostate cancer managed with data-driven active surveillance protocols,' Attalla, who wasn't involved in the study, told Medscape Medical News . The analysis was published online earlier this month in the Journal of the National Comprehensive Cancer Network. Addressing a Data Gap Men with nonmetastatic prostate cancer have a long disease trajectory, and it's well known that the competing risk for death from other causes is high. However, there are only limited data on long-term outcomes for men treated for prostate cancer according to current guideline recommendations. To investigate, Scilipoti and colleagues used Swedish registry data to identify 62,839 men diagnosed with nonmetastatic prostate cancer between 2000 and 2020. At diagnosis, their median age was 67 years and median life expectancy was 18 years. All had a defined risk category and received primary treatment consistent with current NCCN guidelines (v4.2023): Most often that meant radical prostatectomy (42%), radiotherapy with or without androgen deprivation therapy (22%), or active surveillance (20%). Among the 15,531 men with low-risk disease, 71% underwent active surveillance. The researchers simulated patients' risk of dying from prostate cancer or other causes at 15 and 30 years, according to risk category and life expectancy at diagnosis. For men with low-risk prostate cancer, the simulated 15-year prostate cancer mortality rate was 5.5%, whereas mortality from other causes was 37%. Prostate cancer mortality was highest among men with very high-risk disease, at 22%, but the rate of death from competing causes was still higher (36%). At 30 years, the simulated estimate for prostate cancer mortality was 12% among low-risk men, whereas the mortality rate from other causes was 77%. Estimates for men with favorable intermediate-risk cancer were almost identical. Even for men with higher-risk disease, the likelihood of dying from causes other than prostate cancer was two to three times higher: At 30-years, researchers estimated a 20% mortality rate from prostate cancer vs 67% from other causes among men with high-risk disease, and 30% vs 63% among men with very high-risk disease. Within each risk category, deaths due to prostate cancer and other causes varied by life expectancy. For example, when men with low-risk disease had a life expectancy of over 15 years, their estimated 15-year prostate cancer mortality was just 2.5%. That rose to 10% among low-risk men with a life expectancy of < 10 years. Mortality from other causes was higher and ranged from 20% to 81%, respectively, in men with a life expectancy of > 15 years and < 10 years. 'This study offers a big sigh of relief for many men facing a prostate cancer diagnosis,' Ahmad Shabsigh, MD, with The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, and member of the NCCN guidelines panel for prostate cancer, said in the news release. 'What's truly striking is that for patients with low-risk prostate cancer, many of whom were on active surveillance, the 30-year mortality risk from the cancer itself was only about 11%,' said Shabsigh, who was not involved in the research. 'It really underscores the power of evidence-based treatment plans and the importance of focusing on a person's overall health, not just their cancer.' Attala noted that while the overtreatment of prostate cancer has long been an issue, active surveillance has more than doubled over the last decade in the US. 'As our understanding of tumor biology and our ability to risk-stratify men with prostate cancer improved, the rates of offering and implementation of active surveillance for appropriate candidates were seen to increase in tandem,' Attala said. Still, he added, rates of active surveillance vary widely across practices and individual providers. The new data 'should serve to further attest to the long-term safety of active surveillance for men with low-risk prostate cancer,' Attala said. He cautioned, however, that patient safety depends on adherence to the quality protocol detailed in the guidelines — and that does not always happen in current practice. For example, Attala pointed out that confirmatory testing is recommended following a diagnosis of low-risk disease, to facilitate early identification of men who may be at higher risk for future grade reclassification or progression. However, recent data suggest that only a little over half of urologists are offering confirmatory testing following the initial biopsy. 'The rates of grade reclassification with confirmatory testing are not insignificant — upwards of 25% in some studies,' Attala pointed out. 'Altogether, this study and others highlight that optimal outcomes on active surveillance are derived from optimal guideline-driven practices.'

Da Vinci Malfunctions: How Safe Is Robotic Surgery?
Da Vinci Malfunctions: How Safe Is Robotic Surgery?

Medscape

timea day ago

  • Medscape

Da Vinci Malfunctions: How Safe Is Robotic Surgery?

The da Vinci robotic surgical system, developed by Intuitive Surgical, is the most widely used robot-assisted surgical platform worldwide. This enables surgeons to perform minimally invasive procedures with enhanced precision, flexibility, and control. For the first time, a systematic review and two real-world studies confirmed the safety and effectiveness of the system. These findings establish a new benchmark for the future of robotic surgery worldwide. Over the past two decades, robotic surgery has significantly reshaped surgical care, offering improved precision and less invasiveness than traditional approaches. The da Vinci system currently dominates the global market, with more than 2.6 million procedures performed in 2024. In Italy, da Vinci platforms have been in use for over 25 years and are now installed in more than 200 hospitals, where they have been used to treat hundreds of thousands of patients each year. Despite this widespread adoption, comprehensive safety analyses, particularly regarding the frequency and clinical impact of technical malfunctions, are lacking. This is a key gap, particularly as new robotic platforms are emerging and must be evaluated against current standards. Surgery Comparison The COMPARE study, published in the Annals of Surgery , is the largest comparative analysis to date of robotic, laparoscopic, and open oncologic surgeries. This study reviewed data on 3.9 million procedures from 230 publications across 22 countries. It included 34 randomised controlled trials, 74 prospective studies, and 122 database studies. The procedures examined included seven complex cancer surgeries performed using the da Vinci robotic surgical system between 2010 and 2022: lung lobectomy, total or radical hysterectomy, radical prostatectomy, partial nephrectomy, right colectomy, low anterior resection, and total mesorectal excision and/or intersphincteric resection for rectal cancers. A total of 1,194,559 robotic procedures using the da Vinci system were compared with 1,095,936 laparoscopic and video-assisted thoracoscopic procedures and 1,625,320 open surgeries. The primary outcomes included conversion to open surgery, operative time, estimated blood loss, transfusion rate, length of hospital stay, 30-day postoperative complications, readmissions, reoperations, and mortality rates. Robotic surgery took longer than laparoscopy (mean difference [MD], 17.73 minutes) and open surgery (MD, 40.92 minutes), but this was offset by the key clinical benefits. Hospital stays were shorter than those with laparoscopy (MD, -0.51 days) and open surgery (MD, -1.85 days), and blood loss was significantly lower than that with open surgery (MD, -293.44 mL). Robotic surgery reduced the risk for conversion to open surgery by 56% compared with laparoscopy. The transfusion risk was 21% lower than that of laparoscopy and 75% lower than that of open surgeries. Thirty-day complication rates were 10% and 44% lower than those of laparoscopy and open surgery, respectively. Mortality was reduced by 14% and 46% compared with laparoscopy and open surgery, respectively. Overall, robotic surgery showed improved safety for patients. Few Malfunctions Complications related to technical malfunctions are rare; however, how rare are they? A systematic review published in the World Journal of Urology , led by Nicolò Maria Buffi, MD, and Andrea Piccolini, MD, from the Department of Urology at the IRCCS Humanitas Research Hospital and Humanitas University in Milan, Italy, addressed this question. The review included 25 studies published over the past 20 years, covering 3,308,134 robotic procedures and 12,986 malfunctions of the da Vinci surgical system. Malfunction was defined as any unintended failure involving the robotic console, patient cart, instruments, or accessories that disrupted the workflow, required troubleshooting, caused delays, led to conversion, or resulted in patient injury. Malfunctions were classified as device-related (console or cart) or instrument-related (tools). A related study in European Urology , led by Marco Paciotti, MD, from the Department of Biomedical Sciences, Humanitas University, and the Department of Urology, IRCCS Humanitas Research Hospital, analysed Intuitive Surgical data from 1,835,192 da Vinci X and Xi procedures performed globally in 2022, focusing on system‑generated customer messages, which are alerts generated by the da Vinci system in response to technological problems or incorrect platform use. The meta-analysis reported a malfunction rate of 1%, with device malfunctions in 0.11%, instrument issues in 0.37%, and conversion due to malfunction in 0.09%. Among all the malfunctions, 12.9% led to conversion to open surgery and 7.7% to laparoscopy. Injuries linked to malfunctions were estimated at 0.01%-0.02%, typically minor and mostly due to electrical arcing (193 of 308 cases), causing limited tissue damage or burns. System Reliability Manufacturer data showed that 1,790,244 of the 1,835,192 planned procedures (97.55%) were completed without alerts. Alerts occurred in 44,948 procedures (2.45%), totalling 140,986 events. Of these, 81.18% (114,447 events) resolved without rebooting. Technical support was obtained for 14,231 procedures. Only 1202 procedures (0.07%) were interrupted due to alerts, and 945 cases (0.05%) required conversion. The specific causes of alerts and clinical outcomes were not analysed; therefore, a direct link between alerts and outcomes could not be determined. Setting Standards Buffi emphasised the need for clear benchmarks on the da Vinci system's reliability and malfunctions. 'Over the last 5-6 years, there has been a significant introduction of new robotic systems. Given that the da Vinci system (with which I specify that I have no conflict of interest) has a long history and is considered extremely reliable, I thought it was appropriate to establish benchmarks for the reliability of robotic surgery. This is important because we risk focusing on economics, that is, on the cost of one robotic system compared to another, without considering the advantages and reliability of the machine,' he said to Univadis Italy , a Medscape Network platform. Buffi also highlighted a major gap in the field: 'Currently, there is no true standard for assessing the reliability of robotic systems; only the CE approval process is required.' According to Buffi, the da Vinci platform, particularly the latest models, has proven to be extremely safe. He explained that most issues in robotic surgery are linked to human error rather than flaws in technology. This underscores the crucial need for thorough training and education of healthcare professionals. The key challenge is to effectively evaluate new platforms against current standards and ensure robust quality criteria for new entrants in the market.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store